Insight

Federica Ferrario: Our real-world analysis on SBRT and oligoprogressive Lung Cancer

Federica Ferrario/LinkedIn

Nov 3, 2024, 16:19

Federica Ferrario: Our real-world analysis on SBRT and oligoprogressive Lung Cancer

Federica Ferrario, Radiation Oncology Resident at the University of Milan, shared a post on X about a recent paper by Riccardo Ray Colciago et al. published in Current Oncology.

“Our real-world analysis on SBRT and oligoprogressive Lung Cancer is officially published and open access! TTNT 8 months saves.

Amazing team effort: Riccardo Ray Colciago, Chiara Chissotti, Maria Belmonte, Valeria Faccenda, Denis Panizza, Stefano Arcangeli.”

“Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer”

Authors: Riccardo Ray Colciago, Chiara Chissotti, Federica Ferrario, Diego Luigi Cortinovis, Stefano Arcangeli et al.

Federica Ferrario: Our real-world analysis on SBRT and oligoprogressive Lung Cancer

cancer Chiara Chissotti Denis Panizza Federica Ferrario Lung cancer Maria Belmonte OncoDaily Oncology Riccardo Ray Colciago SBRT Stefano Arcangeli Valeria Faccenda

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage